Global Custom Market Research Reports Provider Company

phone

Kadmon Holdings Inc (KDMN) - Financial and Strategic SWOT Analysis Review

  • Published Date: 29 Aug 2018
  • Number of Pages: 47
  • Category: SWOT Analysis
  • Country: United States of America
Kadmon Holdings Inc (KDMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Kadmon Holdings Inc (Kadmon) is an integrated biopharmaceutical company that discovers, develops and markets small molecules and biologics for autoimmune and fibrotic diseases, various types of cancer, and genetic diseases. The companys pipeline encompasses investigational candidates for the treatment of moderate to severe psoriasis, non-small cell lung cancer, idiopathic pulmonary fibrosis, glioblastoma, and polycystic kidney disease. Its pipeline candidates are based on its small molecule and biologics platforms. It also develops in-licensed product candidates and technologies. The company works in partnership with various pharmaceutical and biopharmaceutical companies to advance its pipeline candidates. Kadmon is headquartered in New York, the US.

Kadmon Holdings Inc Key Recent Developments

Aug 09,2018: Kadmon provides business update and reports second quarter 2018 financial results
May 08,2018: Kadmon Provides Business Update and Reports First Quarter 2018 Financial Results
Mar 06,2018: Kadmon Reports Fourth Quarter And Full Year 2017 Financial Results
Nov 09,2017: Kadmon Provides Business Update and Reports Third Quarter 2017 Financial Results
Aug 11,2017: Kadmon to Present Preclinical Data on ROCK Inhibition in Pulmonary Fibrosis at IPF Summit 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData

3
List of Tables 5
List of Figures 5
Section 1 - About the Company 6
Kadmon Holdings Inc - Key Facts 6
Kadmon Holdings Inc - Key Employees 7
Kadmon Holdings Inc - Key Employee Biographies 8
Kadmon Holdings Inc - Major Products and Services 9
Kadmon Holdings Inc - History 10
Kadmon Holdings Inc - Company Statement 11
Kadmon Holdings Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 Company Analysis 13
Company Overview 13
Kadmon Holdings Inc - Business Description 14
R&D Overview 14
Kadmon Holdings Inc - Corporate Strategy 15
Kadmon Holdings Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Kadmon Holdings Inc - Strengths 16
Kadmon Holdings Inc - Weaknesses 17
Kadmon Holdings Inc - Opportunities 18
Kadmon Holdings Inc - Threats 19
Kadmon Holdings Inc - Key Competitors 20
Section 3 Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 Companys Lifesciences Financial Deals and Alliances 27
Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Kadmon Holdings Inc, Recent Deals Summary 29
Section 5 Companys Recent Developments 30
Aug 09, 2018: Kadmon provides business update and reports second quarter 2018 financial results 30
May 08, 2018: Kadmon Provides Business Update and Reports First Quarter 2018 Financial Results 32
Nov 09, 2017: Kadmon Provides Business Update and Reports Third Quarter 2017 Financial Results 33
Aug 11, 2017: Kadmon to Present Preclinical Data on ROCK Inhibition in Pulmonary Fibrosis at IPF Summit 2017 35
Aug 03, 2017: Kadmon Provides Business Update and Reports Second Quarter 2017 Financial Results 36
Jun 01, 2017: Kadmon Announces Data Demonstrating the Potential of the Companys New GLUT Inhibitors for the Treatment of Autoimmune and Inflammatory Conditions 38
May 15, 2017: Kadmon Provides Business Update and Reports First Quarter 2017 Financial Results 39
Mar 22, 2017: Kadmon Reports Upcoming Milestones and Fourth Quarter and Full Year 2016 Financial Results 41
Section 6 Appendix 43
Methodology 43
Ratio Definitions 43
About GlobalData 47
Contact Us 47
Disclaimer 47

List Of Tables


Kadmon Holdings Inc, Key Facts 6
Kadmon Holdings Inc, Key Employees 7
Kadmon Holdings Inc, Key Employee Biographies 8
Kadmon Holdings Inc, Major Products and Services 9
Kadmon Holdings Inc, History 10
Kadmon Holdings Inc, Subsidiaries 12
Kadmon Holdings Inc, Key Competitors 20
Kadmon Holdings Inc, Ratios based on current share price 21
Kadmon Holdings Inc, Annual Ratios 22
Kadmon Holdings Inc, Annual Ratios (Cont...1) 23
Kadmon Holdings Inc, Interim Ratios 25
Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Kadmon Holdings Inc, Recent Deals Summary 29
Currency Codes 43
Capital Market Ratios 43
Equity Ratios 44
Profitability Ratios 44
Cost Ratios 45
Liquidity Ratios 45
Leverage Ratios 46
Efficiency Ratios 46

List Of Figures


Kadmon Holdings Inc, Performance Chart (2013 - 2017) 24
Kadmon Holdings Inc, Ratio Charts 26
Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Kadmon Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

Copa Holdings, S.A. (CPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Rakuten Inc (4755) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

View Report

Screen Holdings Co., Ltd. (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports